Literature DB >> 8876506

Decreasing disability in the 21st century: the future effects of controlling six fatal and nonfatal conditions.

C Boult1, M Altmann, D Gilbertson, C Yu, R L Kane.   

Abstract

OBJECTIVES: This study assessed the effects of reducing fatal and nonfatal health conditions on the number of functionally limited older Americans in the coming decades.
METHODS: Data from the 1990 census and the Longitudinal Study of Aging were used to project the number of functionally limited older Americans from 2001 to 2049, assuming 1% biennial reductions in five conditions that shorten life expectancy (coronary artery disease, stroke, cancer, diabetes, and confusion) and one condition that decreases functional ability (arthritis).
RESULTS: Decreasing the prevalence of arthritis by 1% every 2 years would lead to a much greater reduction in functional limitation between 2001 and 2049 (4 million person-years) than would decreasing any of the other conditions by the same amount. Decreases in two fatal conditions (cancer and coronary artery disease) would lead to increases in functional limitation (0.9 and 0.1 million person-years, respectively).
CONCLUSIONS: Advances against common nonfatal disabling conditions would be more effective than advances against fatal conditions in blunting the large increase in the functionally limited older population anticipated in the 21st century.

Entities:  

Mesh:

Year:  1996        PMID: 8876506      PMCID: PMC1380648          DOI: 10.2105/ajph.86.10.1388

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  25 in total

1.  The failures of success.

Authors:  E M Gruenberg
Journal:  Milbank Mem Fund Q Health Soc       Date:  1977

2.  The aging of America. Impact on health care costs.

Authors:  E L Schneider; J M Guralnik
Journal:  JAMA       Date:  1990-05-02       Impact factor: 56.272

3.  Knee osteoarthritis and physical functioning: evidence from the NHANES I Epidemiologic Followup Study.

Authors:  M A Davis; W H Ettinger; J M Neuhaus; K P Mallon
Journal:  J Rheumatol       Date:  1991-04       Impact factor: 4.666

Review 4.  Survival of patients with dementia.

Authors:  P T van Dijk; D W Dippel; J D Habbema
Journal:  J Am Geriatr Soc       Date:  1991-06       Impact factor: 5.562

5.  Epidemiological, demographic, and social correlates of disability among the elderly.

Authors:  K G Manton
Journal:  Milbank Q       Date:  1989       Impact factor: 4.911

6.  Transitions in health status among community-dwelling elderly people with arthritis. A national, longitudinal study.

Authors:  E H Yelin; P P Katz
Journal:  Arthritis Rheum       Date:  1990-08

7.  Self-care and assistance from others in coping with functional status limitations among a national sample of older adults.

Authors:  J E Norburn; S L Bernard; T R Konrad; A Woomert; G H DeFriese; W D Kalsbeek; G G Koch; M G Ory
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  1995-03       Impact factor: 4.077

Review 8.  Dynamics of health changes in the oldest old: new perspectives and evidence.

Authors:  K G Manton; B J Soldo
Journal:  Milbank Mem Fund Q Health Soc       Date:  1985

9.  Longer life but worsening health? Trends in health and mortality of middle-aged and older persons.

Authors:  L M Verbrugge
Journal:  Milbank Mem Fund Q Health Soc       Date:  1984

10.  Epidemiology of musculoskeletal impairments and associated disability.

Authors:  L S Cunningham; J L Kelsey
Journal:  Am J Public Health       Date:  1984-06       Impact factor: 9.308

View more
  13 in total

1.  Functional Disability and Associated Chronic Conditions among Geriatric Populations in a Rural Community of India.

Authors:  D Chakrabarty; P K Mandal; N Manna; S Mallik; P Ghosh; C Chatterjee; J C Sardar; M Sau; A K Sinha Roy
Journal:  Ghana Med J       Date:  2010-12

2.  Means and ends: cost-effectiveness and overall costs.

Authors:  M Wildner
Journal:  Am J Public Health       Date:  1998-01       Impact factor: 9.308

3.  Association of advanced age with concentrations of uraemic toxins in CKD.

Authors:  Merita Rroji; Sunny Eloot; Annemie Dhondt; Wim Van Biesen; Griet Glorieux; Nathalie Neirynck; Nele Vandennoortgate; Sophie Liabeuf; Ziad Massy; Raymond Vanholder
Journal:  J Nephrol       Date:  2015-04-10       Impact factor: 3.902

4.  The healthcare burden imposed by liver disease in aging Baby Boomers.

Authors:  Gary L Davis; William L Roberts
Journal:  Curr Gastroenterol Rep       Date:  2010-02

5.  Diabetes predicts long-term disability in an elderly urban cohort: the Northern Manhattan Study.

Authors:  Mandip S Dhamoon; Yeseon Park Moon; Myunghee C Paik; Ralph L Sacco; Mitchell S V Elkind
Journal:  Ann Epidemiol       Date:  2014-01-03       Impact factor: 3.797

6.  Trends in obesity and arthritis among baby boomers and their predecessors, 1971-2002.

Authors:  Suzanne G Leveille; Christina C Wee; Lisa I Iezzoni
Journal:  Am J Public Health       Date:  2005-07-28       Impact factor: 9.308

7.  Understanding the linkages between perceived causative impairment and activity limitations among older people living in the community: a population-based assessment.

Authors:  Wenchun Qu; Margaret G Stineman; Joel E Streim; Dawei Xie
Journal:  Am J Phys Med Rehabil       Date:  2011-06       Impact factor: 2.159

8.  International depiction of the cost of functional independence limitations among older adults living in the community: a systematic review and cost-of-impairment study.

Authors:  Ryan S Falck; Alexis G Percival; Daria Tai; Jennifer C Davis
Journal:  BMC Geriatr       Date:  2022-10-22       Impact factor: 4.070

9.  Disabling symptoms: what do older women report?.

Authors:  Suzanne G Leveille; Linda Fried; Jack M Guralnik
Journal:  J Gen Intern Med       Date:  2002-10       Impact factor: 5.128

10.  The effect of different public health interventions on longevity, morbidity, and years of healthy life.

Authors:  Paula Diehr; Ann Derleth; Liming Cai; Anne B Newman
Journal:  BMC Public Health       Date:  2007-04-05       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.